Related Experiment Videos
Buerger's disease: a 10-year experience in Tehran, Iran
Hassan Tavakoli1, Jalal Rezaii, Khalil Esfandiari
1Amir-Alam Hospital, Medical Sciences/University of Tehran, Tehran, Iran.
Clinical Rheumatology
|January 4, 2008
Summary
This study analyzed 198 Buerger's disease (thromboangiitis obliterans) cases in Iran, finding male smokers predominantly affected by lower limb issues. A significant seasonal admission pattern, with most cases occurring in winter, was observed.
Area of Science:
- Vascular Surgery
- Epidemiology
- Clinical Medicine
Background:
- Buerger's disease (thromboangiitis obliterans) is a rare inflammatory vascular condition.
- Previous epidemiological data on Buerger's disease in Iran is limited.
- The clinical presentation and epidemiology of thromboangiitis obliterans may be evolving.
Purpose of the Study:
- To investigate the epidemiological characteristics of Buerger's disease (thromboangiitis obliterans) in Iran.
- To analyze patient demographics, clinical manifestations, and treatment patterns.
- To identify potential seasonal variations in disease incidence.
Main Methods:
- Retrospective analysis of 198 confirmed cases of thromboangiitis obliterans diagnosed between 1996 and 2006.
- Diagnosis confirmed using Papa's scoring system.
- Data collected on patient demographics, smoking history, affected limbs, and surgical interventions.
Main Results:
- All 198 patients were male, with an average age of 40.5 years.
- All patients were smokers, with an average smoking duration of 22.2 years.
- Lower limb involvement was most common (91.4%), followed by upper limb (2.0%) and combined involvement (6.6%).
- A significant seasonal variation in admissions was noted, with winter being the most frequent season (P < 0.001).
- Surgical interventions included sympathectomy (49.0%), amputation (35.9%), and bypass graft surgery (14.1%).
Conclusions:
- Buerger's disease in Iran primarily affects young to middle-aged male smokers with lower limb ischemia.
- The study confirms a significant seasonal variation in thromboangiitis obliterans admissions, with a peak in winter.
- These findings contribute to understanding the epidemiology and clinical spectrum of Buerger's disease in the region.
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...